Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cartesian Therapeutics, Inc. | Director | Common Stock | 178K | $367K | $2.06 | Jan 2, 2024 | Direct |
Cartesian Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 228K | $180K | $0.79 | Jan 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RNAC | Cartesian Therapeutics, Inc. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Director |
SELB | Cartesian Therapeutics, Inc. | Nov 13, 2023 | 7 | -$69.8K | 4 | Nov 15, 2023 | Director |
SELB | SELECTA BIOSCIENCES INC | Jan 2, 2023 | 1 | $0 | 4 | Jan 4, 2023 | Director |
SELB | SELECTA BIOSCIENCES INC | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |